Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin CR in Postherpetic Neuralgia
NCT01270828Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 17
01
Overview
Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Pregabalin CR with Placebo (2 arms). Primary endpoint: Loss of Therapeutic Response at 13 weeks. Started Mar 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01270828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270828.